Agenus Inc. (AGEN) Q1 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Agenus Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.779 -- 00:00:06.043 Thank you for standing by and welcome to Agen's first quarter 2024 results 00:00:06.043 -- 00:00:11.226 conference call. All lines have been placed on mute to prevent any background noise. 00:00:11.226 -- 00:00:15.389 After the speaker's remarks, there will be a question and answer session. 00:00:15.389 -- 00:00:20.152 If you would like to ask a question during this time, simply press star followed by the 00:00:20.152 -- 00:00:25.356 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:25.356 -- 00:00:30.464 star one again. Thank you. I would now like to turn the call over to Zach Arman, 00:00:30.464 -- 00:00:34.726 Head of Investor Relations. Please go ahead. 00:00:34.927 -- 00:00:38.470 Thank you, Rochelle, and thank you all for joining us today. 00:00:38.470 -- 00:00:43.493 Today's call is being webcast and will be available on our website for replay. 00:00:43.493 -- 00:00:47.456 I'd like to remind you that this call will include forward-looking statements, including 00:00:47.456 -- 00:00:53.060 statements regarding our clinical development, regulatory and commercial plans and timelines, 00:00:53.060 -- 00:00:58.493 as well as timelines for data release and partnership opportunities, among other updates. 00:00:58.493 -- 00:01:03.335 These statements are subject to risks and uncertainties, and we refer you to our SEC 00:01:03.335 -- 00:01:07.957 filings available on our website for more details on these risks. 00:01:07.957 -- 00:01:12.538 Joining me today are Dr. Garrow Arman, Chairman and Chief Executive Officer, Dr. 00:01:12.538 -- 00:01:18.000 Steven O'Day, Chief Medical Officer, and Christine Klaskin, Vice President of Finance. 00:01:18.000 -- 00:01:20.841 Dr. Robin Taylor, Chief Comme...